Access Vascular, Inc. Secures $20 Million in Series B Financing
03/03/21, 2:24 PM
Location
bedfordMoney raised
$20 million
Round Type
series b
Access Vascular, Inc., a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of financing. TVM Capital Life Science led the round with a $15 million commitment, with existing investors also participating.
Company Info
Location
bedford, pennsylvania, united states
Additional Info
Access Vascular was founded in 2015 to address the most common and costly complications of intravenous therapy: infection, thrombosis and phlebitis. The company is developing a suite of venous access devices made from patented biomaterials which are highly biocompatible and are capable of long-term thrombus resistance.